Michael Carulli

Michael Carulli

Chief Financial OfficeratPMV Pharmaceuticals· In the 2024 proxy

Pay in FY2024PMV Pharmaceuticals stock -51.3% the same year

Michael Carulli was paid $1.4M in FY2024 (Dec). PMV Pharmaceuticals stock fell 51.3% that year.

Pay$100 in the stock at the end of FY23 → $49
Pay is from the Summary Compensation Table of each PMV Pharmaceuticals proxy. The stock line is the value of $100 put in the stock at the start, from the price change of each fiscal year. Dividends are not in it.

Experience

  1. PMV PharmaceuticalsPublic company · 2 yr
    • Chief Financial Officer2024 – Present · 2 yrStock in role -55%

Roles come from the proxy statements of each company.

Activity

No new filings about this person in the feed.

Two people shown as one, or a wrong number?